When: Monday, Sept. 25, 2006, 7:00pm
Where: Pound 106
Pharmaceutical manufacturers have increasingly been the focus of both federal and state law enforcement efforts, with a string of settlements involving hundreds of millions of dollars. The investigations have involved allegations of kickbacks being paid to prescribers, health care institutions, and managed care payors, off-label promotion of drugs, and a wide variety of other charges. Advocates of the enforcement efforts contend that the enforcement mechanism is necessary to root out widespread fraud and abuse. Critics charge that the use of enforcement tools is not appropriate, in many cases, because of the lack of federal guidance on a variety of issues that should be dealt with as regulatory matters.
This program will explore these important public policy and legal issues, in part by discussing some of the leading cases. Panelists for this event include Paul Kalb, head of Sidley Austin’s national Health Care Practice group, Bill Sarraille, a senior partner in Sidley Austin’s Health Care Practice Group in Washington, D.C., and Bob Thomas, a former AUSA and now a whistleblower's counsel with Thomas & Associates in Boston, MA.
Dinner will be served.
Please contact Matt Gordon (mpgordon@law.harvard.edu) or Rochelle Lee (rhlee@law.harvard.edu) for more information.